Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Zynerba Pharmaceuticals Ord Shs (ZYNE)

$3.42 0.17 (5.23%)

19:25 EDT ZYNE Stock Quote Delayed 30 Minutes

Volume:

Previous Close $3.42

Market Cap 46.38M

PE Ratio -1.23

EPS -2.79

Volume (Avg. Vol.) 1.49M

Day's Range 3.20 - 3.44

52-Week Range 2.55 - 15.30

Dividend & Yield N/A (N/A)

ZYNE Stock Predictions, Articles, and Zynerba Pharmaceuticals Ord Shs News

From InvestorPlace
From the Web

7 Stocks to Buy With 100% Upside Potential

By Maya Sasson, Writer, TipRanks Oct 23, 2019

Investors are looking for the stocks that have the potential to lift their portfolios to new heights. These investments are the stocks with the strongest long-term growth narratives, capable of delivering massive returns.

Zynerba Stock is a Medical Cannabis Investment You Can Feel Good About

By David Moadel, InvestorPlace Contributor Sep 17, 2019

Thinking about investing in medical cannabis? ZYNE stock is a lesser-known gem with transformative potential.

5 Cannabis Stocks Set for Massive Gains

By Harriet Lefton, Writer, TipRanks Aug 26, 2019

We are on the brink of a massive market opportunity. For instance, a new report by Grand View Research reveals that the global legal marijuana market size is expected to reach $66.3 billion by the end of 2025.

3 Marijuana Stocks to Play the Future of Cannabis Medicine

By Aaron Levitt, InvestorPlace Contributor Aug 6, 2019

Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.

Zynerba Stock Soars on Cannabidiol Patent for Autism Spectrum Disorder

By Bret Kenwell, InvestorPlace Contributor Jun 11, 2019

Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.

7 Marijuana Stocks to Play the CBD Trend

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor May 23, 2019

The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.

Compare Brokers

5 Cannabis Stocks Set to Skyrocket — According to Wall Street’s Top Analysts

By Harriet Lefton, Writer, TipRanks Apr 1, 2019

Investors have heard a ton about cannabis stocks and their ridiculous valuations. But Wall Street analysts say these pot stocks still have a lot of upside ahead.

Zynerba Stock Is Marijuana-Adjacent Play Worth a Look

By Ian Bezek, InvestorPlace Contributor Feb 7, 2019

Zynerba has a CBD gel that looks like a promising treatment for various neurological diseases. What does it mean for ZYNE stock?

Zynerba Pharmaceuticals News: Why ZYNE Stock Is Soaring Today

By William White, InvestorPlace Writer Jan 29, 2019

There's some positive Zynerba Pharmaceuticals news concerning ZYNE stock on Tuesday that has it soaring to incredible heights.

2 Marijuana Biotechs to Watch

By Matt McCall, Editor, MoneyWire Oct 1, 2018

Things may be looking up for marijuana stocks, as a cannabidiol (CBD)-based drug was rescheduled to Schedule 5. These 2 should profit next.

Zynerba Pharmaceuticals Continues Its 3-Day Rally

By William White, InvestorPlace Writer Aug 30, 2018

Zynerba Pharmaceuticals (ZYNE) stock isn't done with its recent rally yet as the stock continues to climb higher on Thursday.

Market Roasts Shares of Zynerba Pharmaceuticals

By Chris Lau, InvestorPlace Contributor Jul 24, 2018

Zynerba's stock sank after the company issued shares at $8. This validated the bearish bets against the stock. What should investors expect next?

Compare Brokers

The 10 Best Stocks for 2017 Contest — The Experts Pull Into the Homestretch!

By Jessica Loder, InvestorPlace Assistant Editor Oct 2, 2017

InvestorPlace's Best Stocks Contest is entering the homestretch! Here's how our experts' picks are holding up through the third quarter.

3 Stocks to Watch on Monday: Alphabet Inc (GOOGL), Zynerba Pharmaceuticals Inc (ZYNE) and Sony Corp (ADR) (SNE)

By Karl Utermohlen, InvestorPlace Writer Aug 7, 2017

Zynerba Pharmaceuticals (ZYNE) crashes by nearly half, Alphabet (GOOGL) responds to anti-diversity letter and Sony (SNE) suffers yet another box-office disappointment.

The 10 Best Stocks for 2017 Contest – The Experts Lead at Halftime!

By Jessica Loder, InvestorPlace Assistant Editor Jul 7, 2017

Former leaders have fallen and former laggards in the Best Stocks for 2017 contest have risen to the occasion -- check out the rankings!

The 10 Best Stocks to Buy for 2017: Still the Best?

By Jessica Loder, InvestorPlace Assistant Editor Apr 10, 2017

The experts' pick in the 10 Best Stocks for 2017 contest are trouncing the market so far. But where will these stocks to buy go from here?

Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Stock Dominates in Q1

By Adam Johnson, Founder and Author, Bullseye Brief Apr 6, 2017

Zynerba is working to bring its marijuana-based medications through trials and investors seem to be rewarding ZYNE stock.

3 Marijuana Stocks to Buy on a Federal Crackdown

By Wayne Duggan, InvestorPlace Contributor Feb 28, 2017

For marijuana stocks like GWPH, ZYNE and INSY, a federal crackdown on marijuana legalization laws is no big deal.

Compare Brokers

Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO

By Portfolio Grader Dec 27, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Hottest Manufacturing Stocks Now – DPRX TCON CATB ZYNE

By Portfolio Grader Dec 23, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

Volatility 101: Should Randolph Bancorp (NASDAQ:RNDB) Shares Have Dropped 38%?

From Simply Wall St May 18, 2020

It’s easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/volatility-101-should-randolph-bancorp-nasdaqrndb-shares-have-dropped-38/">Read More...</a></div>

Analysts Offer Insights on Financial Companies: Marketaxess Holdings (NASDAQ: MKTX), Host Hotels & Resorts (NYSE: HST) and Randolph Bancorp (NASDAQ: RNDB)

From Analyst Ratings May 15, 2020

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Marketaxess Holdings (MKTX – Research Report), Host Hotels & Resorts (HST – Research Report) and Randolph Bancorp (RNDB – Research Report). Marketaxess Holdings (MKTX) In a report released today, Brian Bedell from Deutsche Bank maintained a Hold rating

Does The Randolph Bancorp, Inc. (NASDAQ:RNDB) Share Price Fall With The Market?

From Simply Wall St Apr 13, 2020

If you’re interested in Randolph Bancorp, Inc. (NASDAQ:RNDB), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/does-the-randolph-bancorp-inc-nasdaqrndb-share-price-fall-with-the-market/">Read More...</a></div>

What Kind Of Shareholder Owns Most Randolph Bancorp, Inc. (NASDAQ:RNDB) Stock?

From Simply Wall St Mar 9, 2020

A look at the shareholders of Randolph Bancorp, Inc. (NASDAQ:RNDB) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/what-kind-of-shareholder-owns-most-randolph-bancorp-inc-nasdaqrndb-stock-3/">Read More...</a></div>

Is Randolph Bancorp, Inc.’s (NASDAQ:RNDB) CEO Overpaid Relative To Its Peers?

From Simply Wall St Jan 15, 2020

Jim McDonough has been the CEO of Randolph Bancorp, Inc. (NASDAQ:RNDB) since 2013. First, this article will compare CEO compensation with compensation at similar sized companies. After that, we will<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/is-randolph-bancorp-inc-s-nasdaqrndb-ceo-overpaid-relative-to-its-peers/">Read More...</a></div>

Did You Miss Randolph Bancorp’s (NASDAQ:RNDB) 19% Share Price Gain?

From Simply Wall St Dec 11, 2019

One way to deal with stock volatility is to ensure you have a properly diverse portfolio. Of course, the aim of the game is to pick stocks that do better<div><a class="permalink" href="https://simplywall.st/stocks/us/banks/nasdaq-rndb/randolph-bancorp/news/did-you-miss-randolph-bancorps-nasdaqrndb-19-share-price-gain/">Read More...</a></div>

Navellier Ratings

Powered by Portfolio Grader

Total Grade

F

Strong Sell